Case Study

GlaxoSmithKline and AIDS drugs in South Africa (D): US developments

1 pages
February 2005
Reference: IMD-3-1499

The D- case focuses on the developments in the US markets. The AIDS drugs issue that had begun in South Africa was beginning to feed a “perfect storm” in the US and GSK.

Keywords
Non-market Competition, Ethics, Pharmaceuticals, AIDS
Settings
Africa, South Africa
GlaxoSmithKline, Healthcare, Pharmaceuticals
2001 - 2004
Type
Published Sources
Copyright
© 2005
Available Languages
English
Related material
Teaching note
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics